Therefore, it makes sense that PD-L1 and ICAM-1 correlatedly expressed in gene-expression (Fig. 2F) and gene-immunotherapeutic efficacy (Fig. 2H) in patients with cancers. The gene discussed is ICAM1; the disease is cancer.